Efficacy of tenofovir as intensification of zidovudine/lamivudine/abacavir fixed-dose combination in the treatment of HIV-positive patients

被引：8
|
作者：
Khanlou, H [1 ]
Guyer, B
Farthing, C
机构：
[1] AIDS Healthcare Fdn, Los Angeles, CA USA
[2] Gilead Sci Inc, Foster City, CA 94404 USA
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 38卷 / 05期
关键词：
D O I：
10.1097/01.qai.0000159322.21133.74
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：627 / 628
页数：2
相关论文
共 50 条
  • [31] Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda
    Oyugi, Jessica H.
    Byakika-Tusiime, Jayne
    Ragland, Kathleen
    Laeyendecker, Oliver
    Mugerwa, Roy
    Kityo, Cissy
    Mugyenyi, Peter
    Quinn, Thomas C.
    Bangsberg, David R.
    [J]. AIDS, 2007, 21 (08) : 965 - 971
  • [32] A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment naive subjects
    Staszewski, S
    Katlama, C
    Harrer, T
    Massip, P
    Yeni, P
    Cutrell, A
    Tortell, SM
    Harrigan, RP
    Steel, H
    Lanier, RE
    Pearce, G
    [J]. AIDS, 1998, 12 (16) : F197 - F202
  • [33] A Model-Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed-Dose Combination Approval in Children Living with HIV-1
    Chandasana, Hardik
    Buchanan, Ann M.
    McKenna, Michael
    Brothers, Cindy
    Hyatt, Stephen
    Adkison, Kimberly
    Goyal, Navin
    Tan, Lionel K.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [34] Fixed-dose combination of lamivudine, stavudine and nevirapine in the treatment of pediatric HIV-infection: A preliminary report
    Pensi, Tripti
    [J]. INDIAN PEDIATRICS, 2007, 44 (07) : 519 - 521
  • [35] Formulation, Development and Scale-Up of Fixed-Dose Combination Tablets Containing Zidovudine, Lamivudine and Nevirapine
    Maciel Lavra, Zenia Maria
    Morais de Medeiros, Flavia Patricia
    Ferreira da Silva, Rosali Maria
    Rosa, Talita Atanazio
    Wanderley Sales, Victor de Albuquerque
    Barreto Barros Silva, Laysa Creusa Paes
    Moreira Domingues de Sousa, Andre Luiz
    de Lima, Leduar Guedes
    Rolim, Larissa Araujo
    Rolim Neto, Pedro Jose
    [J]. CURRENT HIV RESEARCH, 2019, 17 (05) : 360 - 367
  • [36] THE FIXED-DOSE COMBINATION OF DORAVIRINE/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE IN TREATMENT-NAIVE HIV-1 INFECTED ADULTS: BUDGET IMPACT ANALYSIS
    Pyadushkina, E.
    Derkach, E., V
    Rozenberg, V
    Ugrekhelidze, D.
    Lobodina, A.
    Baxter, C.
    Beyer, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S554 - S554
  • [37] Safety and Efficacy of Fixed Drug Combination Tenofovir, Lamivudine and Efavirenz to Prevent Transmission of HIV
    Sirohi, Pramendra
    Dabas, Anubhav
    Nehara, Hardeva Ram
    Chhimpa, Atma Ram
    Barodia, Mahesh Kumar
    Kumar, Rakesh
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (07)
  • [38] Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral-experienced HIV-1-infected patients (CAL30001 study)
    LaMarca, A
    Clumeck, N
    Plettenberg, A
    Domingo, P
    Fu, KS
    Craig, C
    Zhao, H
    Watson, M
    Gordon, D
    Scott, T
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (05) : 598 - 606
  • [39] Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with HypertensionFocus on Amlodipine/Valsartan
    Pedro Marques da Silva
    [J]. Clinical Drug Investigation, 2010, 30 : 625 - 641
  • [40] Adverse reactions on switching from tenofovir/lamivudine (3TC) to the fixed-dose combination (FDC) of tenofovir/emtricitabine (FTC)
    Harris, M.
    Toy, J.
    Yip, B.
    Hogg, R.
    Montaner, J.
    [J]. ANTIVIRAL THERAPY, 2007, 12 (06) : L60 - L60
12345